Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 275

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Low-Voltage Myocardium-Guided Ablation Trial of Persistent Atrial Fibrillation

Huo, Yan, Gaspar, Thomas, Schönbauer, Robert, Wójcik, Maciej, Fiedler, Lukas, Roithinger, Franz Xaver, Martinek, Martin, Pürerfellner, Helmut, Kirstein, Bettina, Richter, Utz, Ulbrich, Stefan, Mayer, Julia, Krahnefeld, Olaf, Agdirlioglu, Tolga, Zedda, Angela, Piorkowski, Judith, Piorkowski, Christopher · 2022 · NEJM Evidence

Abstract

BACKGROUND: Clinically effective ablation approaches for patients with persistent atrial fibrillation (AF) are still being debated. So far, ablation targets and strategies beyond pulmonary vein isolation (PVI) have failed to show systematic outcome improvement in randomized controlled clinical trials. METHODS: We conducted a multicenter, randomized trial to determine whether PVI plus individualized substrate ablation of atrial low-voltage myocardium improves outcome in patients with persistent AF. We randomly assigned 324 patients in a 1:1 ratio to receive PVI alone (163 patients; PVI only) or PVI plus substrate modification (161 patients; PVI+SM). The primary study end point was the first recurrence of an atrial arrhythmia longer than 30 seconds after single ablation, with 3 months blanking, using serial 7-day electrocardiogram recordings over 12 months of observation. Patients were also encouraged to receive implantable cardiac monitors. RESULTS: The primary study end point occurred in 75 PVI-only patients (50%) and in 54 PVI+SM patients (35%) (Kaplan–Meier event rate estimates: hazard ratio=0.62, 95% confidence interval [CI]=0.43 to 0.88, log rank P=0.006). Adverse events occurred in three PVI-only patients (1.8%) and in six PVI+SM patients (3.7%) (difference: −1.9 percentage points, 95% CI=−5.5 to 1.7 percentage points). Implant monitoring was used in 242 patients. Among them, 65 PVI-only patients (55%) versus 47 PVI+SM patients (39%) experienced recurrences (difference: 15 percentage points, 95% CI=3 to 28 percentage points). CONCLUSIONS: In this randomized trial, PVI plus individualized ablation of atrial low-voltage myocardium significantly improved outcomes in patients with persistent AF. (ClinicalTrials.gov number, NCT02732626.)

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/evidoa2200141

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 40 references

Cited by

See all 275

Metadata

Authors
Huo, Y., Gaspar, T., Schönbauer, R., Wójcik, M., Fiedler, L., Roithinger, F. X., Martinek, M., Pürerfellner, H., Kirstein, B., Richter, U., Ulbrich, S., Mayer, J., Krahnefeld, O., Agdirlioglu, T., Zedda, A., Piorkowski, J., & Piorkowski, C.
Venue
NEJM Evidence
Published
2022-10-25
Volume
1
Issue
11
Pages
EVIDoa2200141-EVIDoa2200141
ISSN
2766-5526 (ISSN-L)
OpenAlex
W4306809685
Cited by
275
References
40
FWCI
36.56
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Low-Voltage Myocardium-Guided Ablation Trial of Persistent Atrial Fibrillation. https://app.cochat.ai/papers/10.1056/evidoa2200141
The paper
Huo, Y., Gaspar, T., Schönbauer, R., Wójcik, M., Fiedler, L., Roithinger, F. X., Martinek, M., Pürerfellner, H., Kirstein, B., Richter, U., Ulbrich, S., Mayer, J., Krahnefeld, O., Agdirlioglu, T., Zedda, A., Piorkowski, J., & Piorkowski, C. (2022). Low-Voltage Myocardium-Guided Ablation Trial of Persistent Atrial Fibrillation. NEJM Evidence. https://doi.org/10.1056/evidoa2200141

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.